Sign in
4

Changes in Ownership

Alto Neuroscience, Inc. Filed Acc 0001415889-24-002942

Director acquired 23,917 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
York Gwill Director 2024-02-06 Conversion +23,917 23,917 D
Derivatives
York Gwill Director 2024-02-06 Conversion · Series A Preferred Stock −53,196 0 D
Loading xslF345X05/form4-02072024_090216.xml…